JBC Oz Biosciences

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kerry, D. M.
Right arrow Articles by May, B. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kerry, D. M.
Right arrow Articles by May, B. K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 271, Number 47, Issue of November 22, 1996 pp. 29715-29721
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Transcriptional Synergism between Vitamin D-responsive Elements in the Rat 25-Hydroxyvitamin D3 24-Hydroxylase (CYP24) Promoter

(Received for publication, April 8, 1996, and in revised form, August 26, 1996)

David M. Kerry , Prem P. Dwivedi , Christopher N. Hahn , Howard A. Morris , John L. Omdahl and Brian K. May

From the Department of Biochemistry, University of Adelaide, Adelaide, South Australia 5005, Australia and the  Department of Biochemistry, University of New Mexico, Albequerque, New Mexico 87131

Transcription of the CYP24 gene is induced by 1,25-(OH)2D3 through a vitamin D receptor-dependent process. The functional activities of three possible vitamin D response elements (VDREs), located on the antisense strand of the rat CYP24 promoter, were investigated by transient expression of native and mutant promoter constructs in COS-1, JTC-12, and ROS 17/2.8 cells. A putative VDRE with a half-site spacing of 6 base pairs at -249/-232 (VDRE-3) did not contribute to 1,25-(OH)2D3 induced expression in the native promoter, although activity has been reported when the element was fused to the heterologous thymidine kinase promoter. Two VDREs with half-site spacings of 3 base pairs at -150/-136 and -258/-244 (VDRE-1 and VDRE-2, respectively), showed transcriptional synergism in COS-1 cells when treated with 1,25-(OH)2D3 (10-7 to 10-11 M). The contribution of both VDREs was hormone-concentration dependent from 10-10 to 10-12 M, with VDRE-1 demonstrating greatest sensitivity to 1,25-(OH)2D3. Transactivation by VDRE-1 was always greater than VDRE-2, but the converse was observed for the binding of vitamin D receptor-retinoid X receptor complex by each VDRE in gel mobility shift assays. The synergy observed between VDRE-1 and VDRE-2 may have important implications in cellular responses to different circulating levels of 1,25-(OH)2D3.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Nutr.Home page
J. C. Fleet, C. Gliniak, Z. Zhang, Y. Xue, K. B. Smith, R. McCreedy, and S. A. Adedokun
Serum Metabolite Profiles and Target Tissue Gene Expression Define the Effect of Cholecalciferol Intake on Calcium Metabolism in Rats and Mice
J. Nutr., June 1, 2008; 138(6): 1114 - 1120.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
J. Tan, P. P. Dwivedi, P. Anderson, B. K. Nutchey, P. O'Loughlin, H. A. Morris, B. K. May, A. Ferrante, and C. S. Hii
Antineoplastic agents target the 25-hydroxyvitamin D3 24-hydroxylase messenger RNA for degradation: implications in anticancer activity
Mol. Cancer Ther., December 1, 2007; 6(12): 3131 - 3138.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. Song and J. C. Fleet
Intestinal Resistance to 1,25 Dihydroxyvitamin D in Mice Heterozygous for the Vitamin D Receptor Knockout Allele
Endocrinology, March 1, 2007; 148(3): 1396 - 1402.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
S. Sundaram, M. J. Beckman, A. Bajwa, J. Wei, K. M. Smith, G. H. Posner, and D. A. Gewirtz
QW-1624F2-2, a synthetic analogue of 1,25-dihydroxyvitamin D3, enhances the response to other deltanoids and suppresses the invasiveness of human metastatic breast tumor cells.
Mol. Cancer Ther., November 1, 2006; 5(11): 2806 - 2814.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. M. Spach and C. E. Hayes
Vitamin D3 Confers Protection from Autoimmune Encephalomyelitis Only in Female Mice
J. Immunol., September 15, 2005; 175(6): 4119 - 4126.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Ren, L. Nguyen, S. Wu, C. Encinas, J. S. Adams, and M. Hewison
Alternative Splicing of Vitamin D-24-Hydroxylase: A NOVEL MECHANISM FOR THE REGULATION OF EXTRARENAL 1,25-DIHYDROXYVITAMIN D SYNTHESIS
J. Biol. Chem., May 27, 2005; 280(21): 20604 - 20611.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
P. Dhawan, X. Peng, A. L. M. Sutton, P. N. MacDonald, C. M. Croniger, C. Trautwein, M. Centrella, T. L. McCarthy, and S. Christakos
Functional Cooperation between CCAAT/Enhancer-Binding Proteins and the Vitamin D Receptor in Regulation of 25-Hydroxyvitamin D3 24-Hydroxylase
Mol. Cell. Biol., January 1, 2005; 25(1): 472 - 487.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
L. Wang, A. Klopot, J.-N. Freund, L. N. Dowling, S. D. Krasinski, and J. C. Fleet
Control of differentiation-induced calbindin-D9k gene expression in Caco-2 cells by cdx-2 and HNF-1{alpha}
Am J Physiol Gastrointest Liver Physiol, November 1, 2004; 287(5): G943 - G953.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
L. Peng, P. J. Malloy, and D. Feldman
Identification of a Functional Vitamin D Response Element in the Human Insulin-Like Growth Factor Binding Protein-3 Promoter
Mol. Endocrinol., May 1, 2004; 18(5): 1109 - 1119.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
F. Barletta, P. Dhawan, and S. Christakos
Integration of hormone signaling in the regulation of human 25(OH)D3 24-hydroxylase transcription
Am J Physiol Endocrinol Metab, April 1, 2004; 286(4): E598 - E608.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Xie, S. J. Munson, N. Huang, A. A. Portale, W. L. Miller, and D. D. Bikle
The Mechanism of 1,25-Dihydroxyvitamin D3 Autoregulation in Keratinocytes
J. Biol. Chem., September 27, 2002; 277(40): 36987 - 36990.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. P. Dwivedi, C. S. T. Hii, A. Ferrante, J. Tan, C. J. Der, J. L. Omdahl, H. A. Morris, and B. K. May
Role of MAP Kinases in the 1,25-Dihydroxyvitamin D3-induced Transactivation of the Rat Cytochrome P450C24 (CYP24) Promoter. SPECIFIC FUNCTIONS FOR ERK1/ERK2 AND ERK5
J. Biol. Chem., August 9, 2002; 277(33): 29643 - 29653.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
F. Barletta, L. P. Freedman, and S. Christakos
Enhancement of VDR-Mediated Transcription by Phosphorylation: Correlation with Increased Interaction Between the VDR and DRIP205, a Subunit of the VDR-Interacting Protein Coactivator Complex
Mol. Endocrinol., February 1, 2002; 16(2): 301 - 314.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
W. Yang, S. J. Hyllner, and S. Christakos
Interrelationship between signal transduction pathways and 1,25(OH)2D3 in UMR106 osteoblastic cells
Am J Physiol Endocrinol Metab, July 1, 2001; 281(1): E162 - E170.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. Raval-Pandya, P. Dhawan, F. Barletta, and S. Christakos
YY1 Represses Vitamin D Receptor-Mediated 25-Hydroxyvitamin D3 24-Hydroxylase Transcription: Relief of Repression by CREB-Binding Protein
Mol. Endocrinol., June 1, 2001; 15(6): 1035 - 1046.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. P. Dwivedi, J. L. Omdahl, I. Kola, D. A. Hume, and B. K. May
Regulation of Rat Cytochrome P450C24 (CYP24) Gene Expression. EVIDENCE FOR FUNCTIONAL COOPERATION OF Ras-ACTIVATED Ets TRANSCRIPTION FACTORS WITH THE VITAMIN D RECEPTOR IN 1,25-DIHYDROXYVITAMIN D3-MEDIATED INDUCTION
J. Biol. Chem., January 7, 2000; 275(1): 47 - 55.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. J. Lees and M. L. Whitelaw
Multiple Roles of Ligand in Transforming the Dioxin Receptor to an Active Basic Helix-Loop-Helix/PAS Transcription Factor Complex with the Nuclear Protein Arnt
Mol. Cell. Biol., August 1, 1999; 19(8): 5811 - 5822.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
X. F. Kong, X. H. Zhu, Y. L. Pei, D. M. Jackson, and M. F. Holick
Molecular cloning, characterization, and promoter analysis of the human 25-hydroxyvitamin D3-1alpha -hydroxylase gene
PNAS, June 8, 1999; 96(12): 6988 - 6993.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-F. Lee, W.-J. Young, W.-J. Lin, C.-R. Shyr, and C. Chang
Differential Regulation of Direct Repeat 3 Vitamin D3 and Direct Repeat 4 Thyroid Hormone Signaling Pathways by the Human TR4 Orphan Receptor
J. Biol. Chem., June 4, 1999; 274(23): 16198 - 16205.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. H. Wang, R. J. Koenig, T. J. Giordano, A. Myc, N. W. Thompson, and J. R. Baker Jr.
1{alpha},25-Dihydroxyvitamin D3 Up-Regulates Bcl-2 Expression and Protects Normal Human Thyrocytes from Programmed Cell Death
Endocrinology, April 1, 1999; 140(4): 1649 - 1656.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
W. Yang, P. A. Friedman, R. Kumar, J. L. Omdahl, B. K. May, M.-L. Siu-Caldera, G. S. Reddy, and S. Christakos
Expression of 25(OH)D3 24-hydroxylase in distal nephron: coordinate regulation by 1,25(OH)2D3 and cAMP or PTH
Am J Physiol Endocrinol Metab, April 1, 1999; 276(4): E793 - E805.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
G. JONES, S. A. STRUGNELL, and H. F. DeLUCA
Current Understanding of the Molecular Actions of Vitamin D
Physiol Rev, October 1, 1998; 78(4): 1193 - 1231.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. Raval-Pandya, L. P. Freedman, H. Li, and S. Christakos
Thyroid Hormone Receptor Does Not Heterodimerize with the Vitamin D Receptor but Represses Vitamin D Receptor-Mediated Transactivation
Mol. Endocrinol., September 1, 1998; 12(9): 1367 - 1379.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.